The burden of hyperkalaemia in chronic kidney disease: a systematic literature review
This review expands on current research, offering a new perspective specifically focused on CKD patients and wider clinical and economic outcomes. Identification of wider clinical and economic consequences of hyperkalaemia in CKD patients, and the interplay between these risks and the risks of sub-optimal RAASi dosing, justify the need for future research. Clinicians should exercise caution when managing this condition in this complex patient group.
Authors
- J. Floege
- James Fotheringham (ORCID: https://orcid.org/0000-0002-8980-2223)
- J Conejo Mir (ORCID: https://orcid.org/0000-0002-5212-9063)
- Yogesh Punekar (ORCID: https://orcid.org/0000-0002-7531-1319)
- Kevin F. Erickson (ORCID: https://orcid.org/0000-0003-2164-609X)
- Alexandra Ehm
- Jessica Walters
- K Rtveladze
- Andrew Frankel
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Baylor College of Medicine (US)
- IQVIA (United Kingdom) (GB)
- Boehringer Ingelheim (Egypt) (EG)
- RWTH Aachen University (DE)
- University of Sheffield (GB)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1093/ckj/sfaf127
- Citations
- 5
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 7.59
Funders
- Boehringer Ingelheim